Susceptibility of Mitophagy‐Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation
Advanced Science · 2025
DOI: 10.1002/advs.202412593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Shan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal…. Hauptthemen laut MEDLINE: Ferroptosis, Mitophagy, Lipid Peroxidation, Colorectal Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The identification of ferroptosis‐sensitive cancers is critical for the application of ferroptosis‐inducing therapies in cancer therapy. Here, patient‐derived organoid screening models of colorectal cancer are established to identify tumors that are sensitive to ferroptosis‐inducing therapy. This study discovers that patient‐derived tumors characterized by mitophagy deficiency are hypersensitive to ferroptosis‐inducing therapies. Mechanistically, a novel negative feedback regulatory pathway of lipid peroxidation is identified, which is one of the important intrinsic anti‐ferroptosis mechanisms of cancer cells. Lipid peroxidation‐mediated endoplasmic reticulum stress transcriptionally upregulates Parkin to promote mitophagy through ATF4. Mitophagy limits the generation of lipid peroxidation products and subsequently inhibits ferroptosis by inhibiting the accumulation of mitochondrial ROS. Mitophagy‐deficient tumors lack this anti‐ferroptotic mechanism, unleashing the generation of lipid peroxidation and potent ferroptotic cell death induced by erastin, RSL3, cysteine deprivation, radiotherapy, and immunotherapy. More importantly, ferroptosis‐inducing therapy selectively inhibits the growth and distant metastasis of mitophagy‐deficient tumors in vivo. In summary, patient‐derived organoids of colorectal cancer patients for screening ferroptosis‐sensitive tumors are established, providing a paradigm for identifying that patient‐derived tumors are sensitive to ferroptosis‐inducing therapies. This study concludes that mitophagy‐deficient tumors are vulnerable to ferroptosis induction, which may lead to the development of new therapeutic strategies for tumors deficient in mitophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center…
- Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
- Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
- Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
- Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China.
ORCID-Profile: Hai-Liang Zhang
Förderung
- Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Chen, J. H., Li, L. C., Ye, Z. P., Liu, J. N., Chen, Y. H., Hu, B. X., Tang, J. H., Feng, G. K., Li, Z. M., Deng, C. X., Deng, R., Zhu, X. F., & Zhang, H. L. (2025). Susceptibility of Mitophagy‐Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation. Advanced Science. https://doi.org/10.1002/advs.202412593
Vancouver
Liu S, Chen JH, Li LC, Ye ZP, Liu JN, Chen YH, et al. Susceptibility of Mitophagy‐Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation. Advanced Science. 2025. doi:10.1002/advs.202412593
BibTeX
@article{Liu2025,
author = {Liu, Shan and Chen, Jing-Hong and Li, Li-Chao and Ye, Zhi-Peng and Liu, Jian-Nan and Chen, Yu-Hong and Hu, Bing-Xin and Tang, Jia-Hong and Feng, Gong-Kan and Li, Zhi-Ming and Deng, Chu-Xia and Deng, Rong and Zhu, Xiao-Feng and Zhang, Hai-Liang},
title = {Susceptibility of Mitophagy‐Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202412593}
}
EUVIMED